Skip to main content
Log in

Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

In addition to open surgery, curative therapies for prostate cancer now include endoscopic surgery and radiation therapies. Because of the expansion and subdivision of treatment methods for prostate cancer, the medical fee point schedule in Japan was revised in fiscal year 2006. We examined changes in medical income and expenditure after this revision of the medical fee system.

Materials and methods

We studied income and expenditure, after institution of the new medical fee schedule, for the five types of therapies for prostate cancer performed at our hospital: two surgical therapies (radical retropubic prostatectomy and laparoscopic prostatectomy) and three radiation therapies (three-dimensional conformal radiation therapy, 192Ir high-dose-rate brachytherapy, and 125I low-dose-rate brachytherapy).

Results

Low-dose-rate brachytherapy was found to be associated with a profit of yy199 per patient. Laparoscopic prostatectomy, a highly advanced medical treatment that the fee revision changed from a partially insured to an insured procedure, yielded a profit of yy75 672 per patient. However, high-dose-rate brachytherapy was associated with a loss of yy654 016 per patient.

Conclusion

Given the loss in hospital income per patient undergoing high-dose-rate brachytherapy, the medical fee point system for this procedure should be reassessed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Open database: Recent cancer statistics [database on the Internet]. Cancer Information Service, National Cancer Center Web site (in Japanese). [Cited 2008 Nov 30]. Available from: http://ganjoho.ncc.go.jp/public/statistics/pub/update.html.

  2. Ono Y, Nakamura T, Murata K, Tsukuma H, Ajiki W, Oshima A, et al. Future statistics of cancer patients in Japan: forecast up to 2020 based on the analysis of a Bayesian logit age-period-cohort model. In: Oshima A, Kuroishi T, Tajima K, editors. Cancer Statistics White Paper: Incidence/Death/Prognosis-2004. Tokyo: Shinoharashinsha; 2004. p. 201–217 (in Japanese).

    Google Scholar 

  3. Egawa S, Minei S, Iwamura M, Uchida T, Koshiba K. Urinary continence following radical prostatectomy. Jpn J Clin Oncol 1997;27:71–75.

    Article  CAS  PubMed  Google Scholar 

  4. Walsh PC. Radical retropubic prostatectomy: an anatomic approach. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED, editors. Campbell’s urology, vol. 3, 6th edn. Philadelphia: Saunders, 1992. p. 2865–2886.

    Google Scholar 

  5. Egawa S, Kuruma H, Suyama K, Iwamura M, Baba S. Delayed recovery of urinary continence after laparoscopic radical prostatectomy. Int J Urol 2003;10:207–212.

    Article  PubMed  Google Scholar 

  6. Guillonneau B, Vallancien G. Laparoscopic radical prostatectomy: the Montsouris technique. J Urol 2000;163:1643–1649.

    Article  CAS  PubMed  Google Scholar 

  7. Satoh T, Kitano M, Fujita T, Ishiyama H, Niibe Y, Okusa H, et al. High-dose rate iridium-192 brachytherapy boost to external beam radiation therapy for prostate cancer in Japanese men. Jpn J Endourol ESWL 2005;18:273–277.

    Google Scholar 

  8. Ishiyama H, Satoh T, Kitano M, Tsumura H, Kotani S, Okusa H, et al. Four-year experience of interstitial permanent brachytherapy for Japanese men with localized prostate cancer. Jpn J Clin Oncol 2008;38:469–473.

    Article  PubMed  Google Scholar 

  9. Satoh T, Ishiyama H, Matsumoto K, Tsumura H, Kitano M, Hayakawa K, et al. Prostate-specific antigen “bounce” after permanent (125) I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis. BJU Int 2008;25:1–5

    Google Scholar 

  10. Notification of the Director of the Safety Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare, No. 0313001, March 13, 2003.

  11. Notification of the Director-General of the Health Policy Bureau, Ministry of Health, Labour and Welfare, No. 0130006, January 30, 2004.

  12. Yomiuri online [homepage on the Internet; in Japanese]. Tokyo: The Yomiuri Shimbun [cited 2008 Oct 30]. Available from http://www.yomiuri.co.jp/iryou/medi/renai/20050215sr11.htm.

  13. Asahi.com [homepage on the Internet; in Japanese]. Tokyo: The Asahi Shimbun [cited 2008 Nov 5] Available from http://www.asahi.com/kansai/news/kyuukyuu/OSK200802120037. html.

  14. Mouraviev V, Nosnik I, Sun L, Robertson CN, Walther P, Albala D, et al. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience. Urology 2007;69:311–314.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takefumi Satoh.

About this article

Cite this article

Satoh, T., Ishiyama, H., Matsumoto, K. et al. Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience. Jpn J Radiol 27, 348–354 (2009). https://doi.org/10.1007/s11604-009-0356-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-009-0356-x

Key words

Navigation